In September 2021, the FDA received the first consumer complaint about a Cronobacter illness potentially linked to formula produced at Abbott Nutrition's manufacturing facility in Sturgis, Michigan. Additional complaints followed in the months after.
In January 2022, FDA inspectors entered the Sturgis plant and found Cronobacter in environmental samples collected from the facility — on surfaces and in areas where powdered formula was produced. This was a serious finding: it indicated systemic contamination, not an isolated incident.
On February 17, 2022, Abbott voluntarily recalled powdered Similac, Alimentum, and EleCare formulas produced at the Sturgis plant. The FDA issued a public safety alert. Four confirmed infant Cronobacter cases were linked to formula from the facility. Two of those infants died.
The Sturgis plant produced a significant share of the U.S. formula supply. When it shut down, combined with existing supply chain issues from the pandemic, the result was a national formula shortage that affected millions of families through much of 2022.